Splenic vein thrombosis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Splenic vein thrombosis}}
{{Splenic vein thrombosis}}
{{CMG}} ; {{AE}} {{Vbe}}
{{CMG}} ; {{AE}} {{Vbe}}{{SKA}}
==Overview==
==Overview==
[[Splenic vein thrombosis]]  must be differentiated from [[hepatic vein thrombosis]], [[portal vein thrombosis]], [[Testicular cancer|testicular cance]]<nowiki/>r, hyperhomocystenemia, and [[deep vein thrombosis]].
[[Splenic vein thrombosis]]  must be differentiated from [[hepatic vein thrombosis]], [[portal vein thrombosis]], [[Testicular cancer|testicular cance]]<nowiki/>r, hyperhomocystenemia, and [[deep vein thrombosis]].

Revision as of 00:13, 6 February 2018

Splenic vein thrombosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Splenic vein thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Splenic vein thrombosis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Splenic vein thrombosis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Splenic vein thrombosis differential diagnosis

CDC on Splenic vein thrombosis differential diagnosis

Splenic vein thrombosis differential diagnosis in the news

Blogs on Splenic vein thrombosis differential diagnosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Splenic vein thrombosis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]Sunny Kumar MD [3]

Overview

Splenic vein thrombosis must be differentiated from hepatic vein thrombosis, portal vein thrombosis, testicular cancer, hyperhomocystenemia, and deep vein thrombosis.

Differential diagnosis

Splenic vein thrombosis (SVT) must be differentiated from hepatic vein thrombosis (HVT), portal vein thrombosis (PVT), testicular cancer, hyperhomocystenemia, and deep vein thrombosis.[1][2][3]

Disease Abdominal pain Leg swelling Portal HTN Rectal bleeding CT abdomin Doppler US of deep viens Urine chemistry
SVT Present Absent Present Present Thrombosis in SV Normal Normal
HVT Present Absent Present Present Thrombosis in HV Normal Normal
Hyperhomocystenemia Present Absent Present if PVT Present if PVT No specific finding May have thrombosis if deep veins involved Elevated homocysteine
DVT Present Present Absent Absent No specific Thrombosis in deep veins Normal
PVT Present Absent Present Present Thrombosis in PV Normal Normal

References

  1. Venkatesh P, Shaikh N, Malmstrom MF, Kumar VR, Nour B (2014). "Portal, superior mesenteric and splenic vein thrombosis secondary to hyperhomocysteinemia with pernicious anemia: a case report". J Med Case Rep. 8: 286. doi:10.1186/1752-1947-8-286. PMC 4154050. PMID 25155131.
  2. Salazar-Mejía CE, Hernández-Barajas D, Llerena-Hernández E, González-Vela JL, Contreras-Salcido MI, González-Gutiérrez A, Borjas-Almaguer OD, Pérez-Arredondo LA, Wimer-Castillo BO (2017). "Testicular Cancer Presenting as Gastric Variceal Hemorrhage". Case Rep Gastrointest Med. 2017: 4510387. doi:10.1155/2017/4510387. PMC 5695022. PMID 29234547.
  3. Bertrand A, Heissat S, Caron N, Viremouneix L, Pracros JP, Javouhey E, Lachaux A, Mialou V (2014). "[Deep vein thrombosis revealing myeloproliferative syndrome in two adolescents]". Arch Pediatr (in French). 21 (5): 497–500. doi:10.1016/j.arcped.2014.02.019. PMID 24709317.